Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide is a synthetic small molecule compound with the molecular formula C14H10FN5O and a molecular weight of approximately 283.27 g/mol[2][4][8]. It features a benzamide core substituted with a fluorine atom and a tetrazole ring, which are structural motifs often explored for their potential biological activities. The compound is listed in chemical databases such as DrugBank (DB07729), ChEMBL (CHEMBL1213447), and PubChem (CID:6470990)[2][6]. As of now, it is classified as an experimental molecule with no approved therapeutic indications or known clinical development beyond preclinical research[6]. Its mechanism of action, pharmacological targets, and therapeutic applications have not been established in the literature or public drug development pipelines.
- Other names
- 3-Fluoro-N-[3-(2H-tetrazol-5-yl)phenyl]benzamideBenzamide, 3-fluoro-N-[3-(2H-tetrazol-5-yl)phenyl]-N-(3-(1H-tetrazol-5-yl)phenyl)(3-fluorophenyl)carboxamide
02
Targets
GPR35 (G-protein Coupled Receptor 35)CTX-M-9 (CTX-M-9 beta-lactamase)Coagulation Factor IXa
Beyond the preview
Go deeper on 3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide.